|
|
Effect of Angong Niuhuang Pills combined with Butylphthalide on severe cerebral infarction |
HU Xiaofei1 ZHU Xianhua2 ZHOU Yan1 JIN Xiaoping1 |
1.Department of Neurology, Taizhou Hospital, Affiliated Hospital of Wenzhou Medical College, Zhejiang Province, Taizhou 317000, China;
2.Department of Critical Care Medicine, the First People′s Hospital of Linghai, Zhejiang Province, Taizhou 317000, China |
|
|
Abstract Objective To investigate the effect of Angong Niuhuang Pills combined with Butylphthalide on severe cerebral infarction. Methods From January 2015 to December 2017, 88 patients with severe cerebral infarction to the Department of Neurology of Taizhou Hospital Affiliated to Wenzhou Medical University were selected and divided into experimental group and control group according to the random number table method, with 44 patients in each group. The control group was treated with conventional western medicine comprehensive treatment, and the experimental group was treated with Angong Niuhuang Pill combined with Butylphthalide injection on the basis of conventional western medicine comprehensive treatment. The treatment duration of both groups was 14 d. Glasgow coma scale (GCS) and National Institutes of Health Stroke Scale (NIHSS) were scored before treatment, 7 d after treatment and 14 d after treatment, respectively, and serum neuron enolase (NSE) and matrix metalloproteinase-13 (mmp-13) levels were detected. Results The overall efficacy of the experimental group was better than that of the control group (P < 0.05). The GCS scores of the experimental group were higher than that of the control group 7 d and 14 d after treatment (P < 0.05). The NIHSS score, serum NSE level and mmp-13 level 14 d after treatment were lower than those in the control group, and the difference were statistically significant (P < 0.05). Conclusion Angong Niuhuang Pill combined with Butylphthalide injection can reduce the degree of consciousness disorder in patients with severe cerebral infarction, reduce central nervous injury and neurological functional defects, and the effect is better than conventional western medicine comprehensive treatment.
|
|
|
|
|
[1] 郭达云.丁苯酞软胶囊联合尤瑞克林治疗急性脑梗死的疗效观察[J].中国实用神经疾病杂志,2017,20(8):53-55.
[2] 袁齐宏,孙维涛.丁苯酞对脑缺血再灌注大鼠神经功能的影响[J].中国临床药理学杂志,2018,34(14):1616-1618.
[3] Li K,Jia J,Wang Z,et al. Elevated serum levels of NSE and s100β correlate with increased risk of acute cerebral infarction in Asian populations [J]. Med Sci Monit,2015, 21:1879-1888.
[4] Zaheer S,Beg M,Rizvi I,et al. Correlation between serum neuron specific enolase and functional neurological outcome in patients of acute ischemic stroke [J]. Ann Indian Acad Neurol,2013,16(4):504-508.
[5] Ma F,Rodriguez S,Buxo X,et al. Plasma matrix metalloproteinases in patients with stroke during intensive rehabilitation therapy [J]. Arch Phys Med Rehabil,2016,97,(11):1832-1840.
[6] 中华医学会神经病学分会脑血管病学组.中国急性期缺血性脑卒中诊治指南2014[J].中华神经科杂志,2015,48(4):246-257.
[7] 毕国力,戴敏方,吴昆华,等.3T磁敏感成像在弥漫性轴索损伤中的应用及与GCS评分的相关性[J].临床放射学杂志,2012,31(1):11-15.
[8] 杜丽.探讨纳洛酮联合醒脑静治疗脑血管病意识障碍的临床效果[J].当代医学,2016,22(15):137-138.
[9] 董世芬,楼黎明,张硕峰,等.安宫牛黄丸(含天然麝香或人工麝香)对实验性脑缺血的保护作用[J].世界科学技术中医药现代化,2013,15(1):85-90.
[10] 颜俊文,陈澜,王艳英,等.安宫牛黄丸对大鼠脑缺血再灌注损伤和脑外伤的保护作用[J].遵义医学院学报,2017, 40(3):249-253.
[11] 卓杰,闰华.静脉注射纳美芬联合鼻饲安官牛黄丸治疗脑干出血导致的意识障碍[J].中药材,2014,37(4):717-719.
[12] 纪海茹,孔令伟,孔维,等.丁苯酞预处理对大鼠脑缺血再灌注损伤后脑水肿和血脑屏障的影响[J].中风与神经疾病杂志,2014,31(8):698-700.
[13] 王喜丰,李刚,付群芳,等.丁苯酞注射液对急性大面积脑梗死体积及基质金属蛋白酶-9的影响[J].中国卒中杂志,2018,13(1):54-57.
[14] 解龙昌,张波,高庆春,等.丁苯酞可以减轻缺氧缺糖条件下血管内皮细胞的线粒体损伤[J].中国病理生理杂志,2014,30(2):339-342.
[15] 王国印,侯婧.依达拉奉联合丁苯酞治疗急性脑梗死疗效观察及对血清C反应蛋白的影响[J].中国医药,2013, 8(8):1079-1080.
[16] 吴赛珍,陈力宇,郑兢,等.丁苯酞注射液治疗分水岭脑梗死伴进展性神经功能恶化疗效观察[J].心脑血管病防治,2016,16(2):153-155.
[17] 库亚萍,周盛年.丁苯酞对大鼠局灶性脑缺血再灌注后NF-κB与p38MAPK表达的影响[J].脑与神经疾病杂志,2018,26(3):150-153.
[18] 李毓新,胡敏.丁苯酞对大鼠脑组织缺血再灌注损伤的保护作用及相关分子机制研究[J].海南医学院学报,2017, 23(7):868-871.
[19] 林绍鹏,殷建瑞.血清神经元烯醇化酶水平对急性脑梗死患者转归的预测价值[J].山东医药,2014,54(4):7-9.
[20] Cheng F,Yuan Q,Yang J,et al. The prognostic value of serum neuron-specific enolase in traumatic brain injury: systematic review and meta-analysis [J]. PLoS One,2014, 9(9):e 106 680.
[21] Quillard T,Tesmenitsky Y,Croce K,et al. Selective inhibition of matrix metalloproteinase-13 increases collagen content of established mouse atherosclerosis [J]. Arterioscler Thromb Vasc Biol,2011,31(11):2464-2472. |
|
|
|